TrialDiabetes, obesity & metabolism2025

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.

Amina Z Haggag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.